IL6 and neoplasm: In tumor tissue, high levels of IL-6 (>3000 pg/100 mg tumor) were observed exclusively in imidazoquinoline-treated tumors, which on average had four times higher levels than placebo-treated tumors (P < 0.01) (Figures 7(a) and 7(b)).